George David Kelly - Director, Iterum Therapeutics Plc

As of December 4, 2018


George David Kelly Net Worth

  • Net worth is estimated to be at least $1.86M
  • Owns at least 19,548 units of Iterum Therapeutics Plc stock

George David Kelly Trading

  • Largest purchase of shares was 10,000 units , worth over $62.89K on December 4, 2018
  • In total has made about 1 transaction recently
  • Usually trades in December, with the busiest year in 2018
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

George David Kelly Mailing Address

  • Mailing address is C/o Horizon Pharma Plc Adelaide Chambers, Peter Street Dublin 8 L2 NONE Ireland

Iterum Therapeutics Plc Insider Trading

  • The most recent transaction was 20,619,949 units sold on February 12, 2021 by Alexander Denner, Sarissa Capital Management Lp, Sarissa Capital Offshore Master Fund Lp, Sarissa Capital Catapult Fund Llc, Sarissa Capital Hawkeye Fund Lp and Sarissa Capital Master Fund Ii Lp worth over $50.01M
  • In the last 3 years, insiders at Iterum Therapeutics Plc sold an estimated value of $51.18M and bought an estimated value of $57.37M
  • The most active traders are Michael W Dunne, Director,  Mark Chin, Director,  and David George Kelly, Director
  • Insider trading is most common in May, with the busiest year in 2018

Iterum Therapeutics plc Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1